Abstract:Immunosenescence refers to the immune system changes observed in individuals over 50 years old, characterized by diminished immune response and chronic inflammation. Recent investigations have highlighted similar immune alterations in patients with reduced kidney function. The immune system and kidney function have been found to be closely interconnected. Studies have shown that as kidney function declines, both innate and adaptive immunity are affected. Chronic kidney disease (CKD) patients exhibit decreased levels of naive and regular T cells, as well as naive and memory B cells, while memory T cell counts increase. Furthermore, research suggests that CKD and end-stage kidney disease (ESKD) patients experience early thymic dysfunction and heightened homeostatic proliferation of naive T cells. In addition to reduced thymic T cell production, CKD patients display shorter telomeres in both CD4+ and CD8+ T cells. Declining kidney function induces uremic conditions, which alter the intestinal metabolic environment and promote pathogen overgrowth while reducing diversity. This dysbiosis-driven imbalance in the gut microbiota can result in elevated production of uremic toxins, which, in turn, enter the systemic circulation due to compromised gut barrier function under uremic conditions. The accumulation of gut-derived uremic toxins exacerbates local and systemic kidney inflammation. Immune-mediated kidney damage occurs due to the activation of immune cells in the intestine as a consequence of dysbiosis, leading to the production of cytokines and soluble urokinase-type plasminogen activator receptor (suPAR), thereby contributing to kidney inflammation. In this review, we delve into the fundamental mechanisms of immunosenescence in CKD, encompassing alterations in adaptive immunity, gut dysbiosis, and an overview of the clinical findings pertaining to immunosenescence.

Characteristics of T cell premature senescence in maintenance hemodialysis patients

Premature Aging of Circulating T Cells Predicts All-Cause Mortality in Hemodialysis Patients

Decreased Peripheral Naïve T Cell Number and Its Role in Predicting Cardiovascular and Infection Events in Hemodialysis Patients

Hemodiafiltration May Be Associated with Senescence-Related Phenotypic Alterations of Lymphocytes, Which May Predict Mortality in Patients Undergoing Dialysis

Decreased Percentage of Memory B Cells is Independently Associated with Increased Susceptibility to Infection in Patients on Maintenance Hemodialysis

Molecular Mechanisms of Premature Aging in Hemodialysis: The Complex Interplay between Innate and Adaptive Immune Dysfunction

The Difference of T Cell Phenotypes in End Stage Renal Disease Patients under Different Dialysis Modality.

Factors Associated with the Elevated Percentage of CD4CD69 T Cells in Maintained Hemodialysis Patients

Cellular Senescence, A Novel Therapeutic Target For Mesenchymal Stem Cells In Acute Kidney Injury

Immunological Features of ESRD Patients Undergoing Hemodialysis of Various Ages.

Early Mortality and Risk Analysis in Adult Patients with Maintenance Hemodialysis

Immunosenescence, Gut Dysbiosis, and Chronic Kidney Disease: Interplay and Implications for Clinical Management

CD73 as a T cell dysfunction marker predicting cardiovascular and infection events in patients undergoing hemodialysis

Enhanced Apoptosis And Senescence Of Bone Marrow-Derived Mesenchymal Stem Cells From Patients With Systemic Lupus Erythematosus

The Proportion of Memory CD8+ T Cell Predicts Infection Event in Patients with Peritoneal Dialysis

Increased Level of Free-Circulating MtDNA in Maintenance Hemodialysis Patients: Possible Role in Systemic Inflammation.

Uremia-Associated Ageing of the Thymus and Adaptive Immune Responses

Lymphocyte Depletion and Subset Alteration Correlate to Renal Function in Chronic Kidney Disease Patients

Progress of Research on Mortality Risk Factors in Elderly Patients Undergoing Maintenance Hemodialysis

Causes of Early Death in Elderly Patients Undergoing Maintenance Hemodialysis